McKesson’s AAH becomes solus distributor for NHS Scotland vaccine programme


Share post:

McKesson UK’s wholesale arm AAH has been appointed as solus provider of storage and distribution services for seasonal influenza vaccines and other products by NHS Scotland.

The company started distributing these items to community pharmacies spread across 14 regional Health Boards in mainland Scotland and the Western Isles, Orkney and Shetland from October 1, 2021.

Four different types of flu vaccine from Seqirus and Sanfoi Aventis are available to order via AAH along with associated consumables.

In Scotland, the Vaccine Transformation Programme (VTP) is working with NHS Boards, Primary Care and others as necessary to develop and test proposals for future delivery of vaccination programmes.

Separately, Enterprise –  the e-commerce platform of AAH, is introducing a new 48-hour delivery service from November 15.

The new service will enable more frequent deliveries “in state-of-the-art AAH temperature-controlled pharma vans” to help maintain stock levels, it said.

“Products will be the cheaper or the same price as AAH, when purchased as outers from Enterprise” the company said.


Please enter your comment!
Please enter your name here

Current Issue October 2023

Related articles

England lost more than 1,000 pharmacies in the last eight years, says CCA

Community pharmacies are currently facing a worrying mix of funding, workforce, and workload pressures The Company Chemists’ Association...

NHS care delays led to 112 deaths, harmed 8,000 people in England last year

The number of patients dying due to care delays have risen more than fivefold over the last three...

Whitworth Chemists puts six high-dispensing Blackpool pharmacies up for sale

The family-owned business has decided to sell all 34 pharmacies across the North of England Whitworth Chemists Limited...

Babies born with Wolman disease can now receive a life-saving treatment on the NHS

The new enzyme replacement therapy improves patient’s life expectancy and quality of life in clinical trials   For the first...